ArticleFrontiers in oncology2022

Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer.

Liang Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.